top

HanAll BioPharma Receives a Grant for HL161 Auto-Immune Project from Korean Drug Development Fund (KDDF) - 03.27.2015

HanAll Biopharma Co., Ltd. and Open Monoclonal Technology Announce Collaboration - 12.01.2014

HanAll Biopharma Co., Ltd. turns a profit of 0.72 million USD over the first half of fiscal year of 2014 - 10.20.2014

HanAll BioPharma Co., Ltd. to Present at Biotech Showcase™ 2014 - 01.20.2014

SangHee Yoo, PhD. Appointed as a Director of Innovative Drug Discovery team by HanAll BioPharma - 11.26.2013

YuHan Corporation Invests 28 Million USD in HanAll BioPharma - 12.12.2012

HanAll BioPharma Receives a Grant for HL156 Oncology Program from the Korean Government - 06.19.2012

HanAll BioPharma Initiates Phase II Trial of HL009 (Anti-Atopic Dermatitis Gel) in US - 04.20.2012

HanAll BioPharma Initiates Phase III Trial of HL040 (Atorvastatin+Losartan) in Korea and Phase I Trial in US - 04.13.2012

HanAll BioPharma Initiates Phase I Trial of Vitatropin (Oral Human Growth Hormone) - 10.24.2011

맨처음페이지로이동 이전페이지로이동 1 2 3 4 5 다음페이지로이동 마지막페이지로이동